These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 356517)

  • 1. C-peptide in juvenile diabetes.
    Ludvigsson J; Heding LG
    Acta Paediatr Scand Suppl; 1977; (270):53-62. PubMed ID: 356517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-cell function in children with diabetes.
    Ludvigsson J; Heding LG
    Diabetes; 1978; 27 Suppl 1():230-4. PubMed ID: 344114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.
    Ludvigsson J; Heding LG; Larsson Y; Leander E
    Acta Paediatr Scand; 1977 Mar; 66(2):177-84. PubMed ID: 402787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide in children with juvenile diabetes. A preliminary report.
    Ludvigsson J; Heding LG
    Diabetologia; 1976 Dec; 12(6):627-30. PubMed ID: 1001852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal proinsulin/C-peptide ratio in juvenile diabetes.
    Ludvigsson J; Heding L
    Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-types, C-peptide and insulin antibodies in juvenile diabetes.
    Ludvigsson J; Säfwenberg J; Heding LG
    Diabetologia; 1977 Jan; 13(1):13-7. PubMed ID: 838199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-types, C-peptide and insulin antibodies in juvenile diabetics [proceedings].
    Ludvigsson J; Heding L; Säfwenberg J
    Diabete Metab; 1976 Sep; 2(3):158. PubMed ID: 1010130
    [No Abstract]   [Full Text] [Related]  

  • 8. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
    Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide in diabetic children after stimulation with clucagon compared with fasting C-peptide levels in non-diabetic children.
    Ludvigsson J; Heding LG
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):364-71. PubMed ID: 577329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assay of C-peptide in diabetes in children and adolescents].
    Jos J; Kestenbaum S
    Ann Med Interne (Paris); 1984; 135(6):416-9. PubMed ID: 6391322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors of importance for residual beta-cell function in type I diabetes mellitus. A review.
    Madsbad S
    Acta Med Scand Suppl; 1983; 671():61-7. PubMed ID: 6349267
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.
    Eff C; Faber O; Deckert T
    Diabetologia; 1978 Sep; 15(3):169-72. PubMed ID: 359394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human proinsulin in insulin-treated juvenile diabetics.
    Heding LG; Ludvigsson J
    Acta Paediatr Scand Suppl; 1977; (270):48-52. PubMed ID: 278468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 15. Human C-peptide. Part II: Clinical studies.
    Beischer W; Heinze E; Keller L; Raptis S; Kerner W; Pfeiffer EF
    Klin Wochenschr; 1976 Aug; 54(15):717-25. PubMed ID: 824496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.
    Kaas A; Andersen ML; Fredheim S; Hougaard P; Buschard K; Petersen JS; de Beaufort C; Robertson KJ; Hansen L; Mortensen HB; Nielsen LB;
    Pediatr Diabetes; 2012 Feb; 13(1):51-8. PubMed ID: 22118630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy.
    Gerbitz KD; Kemmler W; Edelmann A; Summer J; Mehnert H; Wieland OH
    Eur J Clin Invest; 1979 Dec; 9(6):475-83. PubMed ID: 119646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control.
    Rjasanowski I; Michaelis D; Keilacker H; Besch W; Richter KV; Heinke P
    Exp Clin Endocrinol; 1987 Apr; 89(2):216-24. PubMed ID: 3301371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.
    Garcia-Webb P; Bonser A; Welborn TA
    Diabetologia; 1982 Apr; 22(4):296. PubMed ID: 7047275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.